???astrazeneca_global_websites_new???

• AstraZeneca Worldwide

Main navigation

• Home
• LDL-C lowering
• HDL-C raising
• Well tolerated
• Prescribed in millions of patients
• Initiating CRESTOR treatment
• Safety and tolerability
• Prescribing information
• Person behind the numbers
• Clinical research
• Cardiovascular disease background
• Resources
• References
• Event & congresses
• Feedback
• Sitemap
• CRESTOR in your country

You are here

• Home

• Sitemap

• • CRESTOR LDL-C lipid lowering efficacy

    • CRESTOR is the most effective statin at lowering LDL-C [1-29]
    • CRESTOR reduces LDL-C by up to 63% [29]
    • CRESTOR effectively reduces LDL-C across its dose range [1]
    • CRESTOR gets more patients to goal than commonly prescribed doses of other statins [1-5, 14, 21, 22, 30-32]

  • CRESTOR produces significant increase in HDL-C [1]

    • CRESTOR raises HDL-C significantly more than other statins and the effect is maintained across the dose range [1]
    • CRESTOR can reduce triglycerides as effectively as double the dose of atorvastatin [13]

  • CRESTOR is well tolerated and has a favourable benefit-risk profile to that of other marketed statins [38]

  • CRESTOR has been prescribed in more than 12 million patients [data on file]

  • How to initiate treatment with CRESTOR

  • Safety and tolerability

    • Clinical trials
    • CRESTOR Post-marketing surveillance
    • Pharmaco- epidemiology
    • National Lipid Association
    • References safety and tolerability

  • Prescribing information

  • Person behind the numbers

• • Clinical research

    • What is the GALAXY Programme?
    • Current GALAXY Programme studies
    • Bibliography

  • Cardiovascular disease background

    • Improving CV outcomes
    • Reducing events
    • LDL-C/HDL-C ratio and CHD risk
    • Changes in guidelines
    • Unmet needs
    • Getting to goal
    • References disease background

  • Resources

    • Cardiovascular news
    • Calculators
    • Glossary
    • What's what on dyslipidaemia

  • References

  • Events and congresses

    • Congress reports

  • Feedback

  • CRESTOR in your country

Page tools

• Print
• Bookmark this page

Legal notices

• Legal policy
• Privacy policy
• © AstraZeneca 2008